Skip to content
HowShorted

CORCEPT THERAPEUTICS INC short interest in 2018

In 2018, CORCEPT THERAPEUTICS INC's disclosed short interest ran from 14.30% of shares outstanding on 12 Jan 2018 to 21.20% on 31 Dec 2018, a change of +6.90 percentage points. The year's high was 21.20% on 31 Dec 2018 and its low 12.81% on 15 Feb 2018, averaging 15.97% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 28.89 days on 30 Nov 2018. Full history: CORCEPT THERAPEUTICS INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for CORCEPT THERAPEUTICS INC in 2018

2018 in figures

Start of year
14.30% (12 Jan 2018)
End of year
21.20% (31 Dec 2018)
Change
+6.90 pp
High
21.20% (31 Dec 2018)
Low
12.81% (15 Feb 2018)
Average
15.97%
Highest days to cover
28.89 (30 Nov 2018)
SEC filings marked
9

Every report in 2018

CORCEPT THERAPEUTICS INC short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 201814.30%9.99
31 Jan 201813.66%7.05
15 Feb 201812.81%4.56results (8-K)
28 Feb 201814.28%8.04results (8-K), 10-K filed
15 Mar 201814.10%9.98
29 Mar 201815.10%10.01
13 Apr 201814.93%16.38
30 Apr 201815.33%20.91
15 May 201815.45%12.72results (8-K), 10-Q filed
31 May 201815.02%16.43
15 Jun 201815.09%18.33
29 Jun 201815.20%11.21
13 Jul 201814.56%14.81
31 Jul 201815.73%14.78
15 Aug 201813.05%7.9110-Q filed, results (8-K)
31 Aug 201813.68%13.56
14 Sep 201816.09%15.10
28 Sep 201816.40%17.22
15 Oct 201816.89%18.20
31 Oct 201818.33%18.35
15 Nov 201820.35%18.46results (8-K), 10-Q filed
30 Nov 201820.95%28.89
14 Dec 201820.74%7.81
31 Dec 201821.20%15.67

See also: CORCEPT THERAPEUTICS INC's full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.